Thiopental Sodium Property

solubility 

H₂O: >10 mg/mL

color 

Yellowish hygroscopic powder

EPA Substance Registry System

Thiopental sodium (71-73-8)

Safety

Hazard Codes 

T

Risk Statements 

25

Safety Statements 

36-45

RIDADR 

UN 2811 6.1/PG 3

WGK Germany 

3

RTECS 

CQ6475000

HazardClass 

6.1(b)

PackingGroup 

III

Toxicity

LD50 in mice (mg/kg): 149 i.p.; 78 i.v. (Christensen, Lee)

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Danger

Hazard statements

H301Toxic if swalloed

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

P321Specific treatment (see … on this label).

P330Rinse mouth.

P405Store locked up.

P501Dispose of contents/container to..…

Thiopental Sodium Chemical Properties,Usage,Production

Description

Thiopental sodium , the sodium salt of 5-ethyl-5-(1-methylbutyl)thiobarbituric acid, a yellowish-white, crystalline, slightly bitter powder, is very soluble in water and soluble in alcohol. The compound is hygroscopic and has a weak unpleasant odor. The free acid forms colorless crystals, mp 158 – 159 ?C.A10%solution of the sodium salt has a pH of 10.6.

Chemical Properties

Yellowish-white, hygroscopic powder.

Uses

Pentothal (Abbott).

Definition

A rapidly acting barbiturate administered intravenously for general anesthesia and hypnosis. Commonly known as “truth serum.”

brand name

Thiopental is BAN.

Hazard

May cause respiratory failure; use onlywith physician in attendance.

Pharmacokinetics

Thiopental is highly bound to albumin, and free drug availability is increased in hypoproteinaemia. Protein binding is decreased by alkalaemia, hyperventilation and some drugs that occupy the same albumin binding sites, thereby increasing unbound thiopental concentrations. Metabolism occurs predominantly in the liver, and the metabolites are excreted by the kidneys. Only a small proportion is excreted unchanged in the urine. The terminal elimination half-life is approximately 11.5h (longer in the elderly). Elimination after an infusion is a zero-order process with 10%–15% of the remaining drug metabolised each hour. Up to 30% of the original dose may remain in the body at 24h, and a hangover effect is common. Accumulation may result if further doses of thiopental are administered within 1–2 days.

Clinical Use

Thiopental sodium is a short-acting intravenous anesthetic used for brief surgical procedures and induction of anesthesia. It is a potent,rapidly effective hypnotic. Sleep ensues within 30 – 60 s. A disadvantage is the lengthy hangover. In the United States and Great Britain it is the most widely used injection anesthetic. Abuse can lead to addiction.

Safety Profile

Poison by ingestion, intraperitoneal, rectal, subcutaneous, and intravenous routes. Human systemic effects by intraarterial route: acute arterial occlusion; by rectal route: respiratory depression, body temperature decrease, general anesthetic. An experimental teratogen. Experimental reproductive effects. An intravenous anesthetic. When heated to decomposition it emits toxic fumes of NO, and Na2O. See also PENTOTHAL and BARBITURATES

Veterinary Drugs and Treatments

Because of its rapid action and short duration, in young, healthy animals, thiopental is excellent induction agent (rapid IV bolus) for general anesthesia with other anesthetics or as the sole anesthetic agent for very short procedures. In sick or debilitated animals, thiopental may be used in a more cautious manner (IV, slowly to effect).